A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

(2017) J Pullman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections

(2016) A. Russo et al.   CLINICAL MICROBIOLOGY AND INFECTION

How to stratify patients at risk for resistant bugs in skin and soft tissue infections?

(2016) Cristina Vazquez Guillamet et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A Thorough QT Study To Evaluate the Effects of Therapeutic and Supratherapeutic Doses of Delafloxacin on Cardiac Repolarization

(2015) Jeffrey S. Litwin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study

(2015) Javier Garau et al.   BMC INFECTIOUS DISEASES

Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy

(2015) Françoise Van Bambeke   Future Microbiology

Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting

(2015) V. Ektare et al.   JOURNAL OF MEDICAL ECONOMICS

Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study

(2014) B.A. Lipsky et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors

(2014) B.A. Lipsky et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Initial Treatment Failure in Patients with Complicated Skin and Skin Structure Infections

(2013) Ariel Berger et al.   Surgical Infections

Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization

(2012) J. M. Remy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess

(2012) Jenana Halilovic et al.   JOURNAL OF INFECTION

Outcomes and management costs in patients hospitalized for skin and skin-structure infections

(2010) Kamal M.F. Itani et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Hospitalizations with healthcare-associated complicated skin and skin structure infections: Impact of inappropriate empiric therapy on outcomes

(2010) Marya D. Zilberberg et al.   Journal of Hospital Medicine

Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors

(2009) Marya D. Zilberberg et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Surgical Site Infections: Does Inadequate Antibiotic Therapy Affect Patient Outcomes?

(2009) Kathryn J. Eagye et al.   Surgical Infections